| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |